chr21-46136986-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001320412.2(FTCD):c.1607C>T(p.Thr536Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000854 in 1,612,962 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001320412.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTCD | NM_206965.2 | c.*1C>T | 3_prime_UTR_variant | 14/14 | ENST00000397746.8 | NP_996848.1 | ||
FTCD | NM_001320412.2 | c.1607C>T | p.Thr536Met | missense_variant | 14/15 | NP_001307341.1 | ||
FTCD | NM_006657.3 | c.*1C>T | splice_region_variant | 14/15 | NP_006648.1 | |||
FTCD | NM_006657.3 | c.*1C>T | 3_prime_UTR_variant | 14/15 | NP_006648.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FTCD | ENST00000397746 | c.*1C>T | 3_prime_UTR_variant | 14/14 | 1 | NM_206965.2 | ENSP00000380854.3 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152172Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000359 AC: 89AN: 247588Hom.: 0 AF XY: 0.000312 AC XY: 42AN XY: 134496
GnomAD4 exome AF: 0.000896 AC: 1309AN: 1460790Hom.: 2 Cov.: 36 AF XY: 0.000820 AC XY: 596AN XY: 726648
GnomAD4 genome AF: 0.000447 AC: 68AN: 152172Hom.: 0 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74322
ClinVar
Submissions by phenotype
Glutamate formiminotransferase deficiency Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center | May 02, 2022 | This sequence variant is a single nucleotide substitution (C>T) at the first nucleotide of the 3' UTR of the FTCD gene. This variant has not been clinically annotated previously (ClinVar), and has not been observed in patients with FTCD-related disease in the literature, to our knowledge. This variant is present in control population datasets (gnomAD database 103 of 278956 alleles or 0.04%). Bioinformatic tools do not predict any effect of this variant on splicing, and this nucleotide is not well conserved across the species examined. Functiol studies testing the effect of this variant on protein expression have not been performed, to our knowledge. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider this to be a variant of uncertain significance. ACMG Criteria: BP7 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at